The Infectious Disease Research Institute (IDRI) was a non-profit organization based in Seattle, in the United States, and which conducts global health research on infectious diseases. Its new name is Access to Advanced Health Institute (AAHI).
History
editIDRI was founded in 1993, by Steve Reed, PhD. [1]
Malaria vaccine
editIDRI is collaborating with the United States Agency for International Development to develop a malaria vaccine with the Walter Reed Army Institute of Research using Walter Reed's CelTOS malaria antigen in conjunction with IDRI's GLA-SE adjuvant.[2]
Visceral leishmaniasis vaccine
editIn February 2012, IDRI launched the world's first clinical trial of the visceral leishmaniasis vaccine. The vaccine is a recombinant form of two fused Leishmania parasite proteins with an adjuvant. Two phase 1 clinical trials with healthy volunteers are to be conducted. The first one takes place in Washington and is followed by a trial in India. The trials are funded by the Bill & Melinda Gates Foundation.[3]
References
edit- ^ "Home". idri.org. Archived from the original on 2009-03-26. Retrieved 2011-09-12.
- ^ Erica Teichert (18 August 2011). "USAID, IDRI form malaria vax collaboration". fiercevaccines.com. Archived from the original on November 9, 2011. Retrieved 12 September 2011.
{{cite web}}: CS1 maint: unfit URL (link) - ^ Elvidge, Suzanne (February 23, 2012). "World's first kala azar vaccine enters the clinic". FierceVaccines.com. Archived from the original on February 22, 2014. Retrieved March 1, 2012.
{{cite web}}: CS1 maint: unfit URL (link)